Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots
Teva Pharmaceutical expects to finalize an opioid settlement in the U.S. by year-end and start paying in 2023.
Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots
Teva Pharmaceutical expects to finalize an opioid settlement in the U.S. by year-end and start paying in 2023.